Kelen
☆    

Brazil,
2020-06-29 20:51
(994 d 06:49 ago)

Posting: # 21605
Views: 1,000
 

 Transdermal [Regulatives / Guidelines]

Hi everyone,
In Brazil we are implementing the guideline about generic transdermal products and I have some doubts about the EMA Guideline.

(1) About the sensitisation and irritation test, is it dependent on how the medication is used or should it always be done as described in the guide, a patch every day even if the patch is to be used for more than 24 hours?

(2) Is a multiple dose study necessary if accumulation is observed or is there any other condition that would dispense this study with transdermal patches?

I would appreciate a lot any kind of help.
Thanks in advance!

Kelen
UA Flag
Activity
 Admin contact
22,546 posts in 4,721 threads, 1,608 registered users;
17 visitors (0 registered, 17 guests [including 8 identified bots]).
Forum time: 02:41 CET (Europe/Vienna)

Science is the great antidote to the poison
of enthusiasm and superstition.    Adam Smith

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5